Bellerophon Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 13 Oct 23 | SellUS$111,776 | Puissance Capital Management LP | Company | 1,076,841 | US$0.10 | |
| 07 Jun 23 | SellUS$111,569 | Puissance Capital Management LP | Company | 134,421 | US$0.83 | |
| 18 May 23 | SellUS$5,297,600 | Puissance Capital Management LP | Company | 560,000 | US$9.46 | |
| 18 May 23 | SellUS$81,670 | Bobae Kim | Individual | 8,167 | US$10.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 0 | 0% |
| Institutions | 204,117 | 1.67% |
| Individual Insiders | 1,002,650 | 8.2% |
| Hedge Funds | 1,026,868 | 8.39% |
| General Public | 9,999,013 | 81.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 1,026,868 | US$56.6k | 0% | 100.0% | |||
| 642,844 | US$35.4k | 0% | no data | |||
| 199,600 | US$11.0k | -47.9% | no data | |||
| 196,670 | US$10.8k | -19.5% | no data | |||
| 60,913 | US$3.4k | 0% | no data | |||
| 34,649 | US$1.9k | 0% | no data | |||
| 25,973 | US$1.4k | 0% | no data | |||
| 24,705 | US$1.4k | 0% | no data | |||
| 12,470 | US$687.1 | 0% | no data | |||
| 4,517 | US$248.9 | 0% | no data | |||
| 1,723 | US$95.0 | 0% | no data | |||
| 1,457 | US$80.3 | 0% | no data | |||
| 1,246 | US$68.7 | 0% | no data |